Compare TTMI & SNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TTMI | SNN |
|---|---|---|
| Founded | 1978 | 1856 |
| Country | United States | United Kingdom |
| Employees | N/A | 16988 |
| Industry | Electrical Products | Industrial Specialties |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.6B | 14.3B |
| IPO Year | 2000 | N/A |
| Metric | TTMI | SNN |
|---|---|---|
| Price | $172.12 | $30.90 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 2 |
| Target Price | ★ $127.25 | $36.25 |
| AVG Volume (30 Days) | ★ 2.5M | 1.1M |
| Earning Date | 04-29-2026 | 03-16-2026 |
| Dividend Yield | N/A | ★ 2.48% |
| EPS Growth | ★ 211.11 | N/A |
| EPS | ★ 0.47 | N/A |
| Revenue | ★ $2,906,345,000.00 | N/A |
| Revenue This Year | $18.60 | $8.58 |
| Revenue Next Year | $16.91 | $5.60 |
| P/E Ratio | $369.91 | ★ $64.97 |
| Revenue Growth | ★ 18.98 | N/A |
| 52 Week Low | $35.03 | $28.40 |
| 52 Week High | $200.68 | $38.79 |
| Indicator | TTMI | SNN |
|---|---|---|
| Relative Strength Index (RSI) | 51.40 | 53.25 |
| Support Level | $87.36 | $29.10 |
| Resistance Level | $180.00 | $31.15 |
| Average True Range (ATR) | 14.93 | 0.48 |
| MACD | -2.94 | 0.21 |
| Stochastic Oscillator | 22.64 | 81.58 |
TTM Technologies Inc manufactures technology products, including mission systems, RF components, RF/microwave assemblies, and advanced interconnect products such as PCBs and substrates. It operates through three segments: A&D, Commercial, and RF&S Components. The A&D segment supports aerospace and defense missions with PCBs, assemblies, microelectronics, and integrated systems. The Commercial segment, generating the majority of revenue, serves automotive, medical, industrial, and data center markets. The RF&S Components segment provides TTM-designed RF components and COTS products. The Company's revenues come from PCBs, engineered systems, and long-term contracts for intelligence, surveillance, and communications solutions.
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.